Michael McKenzie, MD FRCPC
University of British Columbia (UBC)
Active Staff: Radiation Oncologist
British Columbia Cancer Agency (BCCA) – Vancouver Centre *
Active Staff – Vancouver Hospital and Health Sciences Centre
Hospital Authority: Provincial Health Services
600 West 10th Avenue
Vancouver, BC V5Z 4E6
Phone: 604.877.6000 extension 2380 Fax: 604.877.0505
Major Clinical Focus – Genitourinary oncology, neuro-oncology, palliative oncology
• Doctor of Medicine, Queen’s University, Canada, 1985
• Fellow of The Royal College of Physicians of Canada, Royal College of Physicians & Surgeons of Canada, Canada, 1990
• Chief Resident (Radiation Oncology), B.C. Cancer Agency, Vancouver British Columbia, Canada, 1990
• Resident (Radiation Oncology), B.C. Cancer Agency, Vancouver British Columbia, Canada, 1987-1990
• Internal Medicine Residency (The R2 Year), Vancouver, British Columbia, Canada, 1986-1987
• Mixed Internship, Montreal general Hospital, Montreal, Quebec, Canada, 1985-1986
Biographic Summary ( Background, Academic Interests and Activities, Clinical Activities )
Dr. McKenzie is a radiation oncologist with extensive experience in genitourinary oncology, neurooncology and palliative oncology. Additional special clinical expertise includes permanent seed implantation for localized adenocarcinoma of the prostate and both stereotactic radiosurgery and stereotactic radiation therapy for intracranial disease. Recently, he concluded a twenty-year tenure as Chair of the British Columbia Cancer Agency’s (BCCA’s) Stereotactic Working Group which oversees British Columbia’s Provincial intracranial stereotactic program. He has extensive experience conducting and leading both investigator-initiated and cooperative group clinical trials. Currently, he is a member of the Clinical Trials Committee at the National Cancer Institute of Canada’s Clinical Trials Group. After new legislation formalizing advance care planning became law in British Columbia in September 2011, Dr. McKenzie has became very active in efforts to implement that legislation at the BCCA, including those to craft a related research agenda. He is also an active member of two interprofessional research teams based at the School of Nursing at The University of British Columbia (UBC). He is a member of The Canadian Association of Radiation Oncology’s Manpower Committee. In addition, he is a member of the Clinical Promotions Committee at the Department of Surgery at UBC.
1. Olson R, Parkinson M, McKenzie M. Selection Bias Introduced by Neuropsychological Assessments. Can J Neurosciences 2010 March;37(2):264-268.
2. Roberge D, Menard C, Bauman G, Chan, A, Mulroy L, Sahgal A, Malone S, McKenzie M, Schroeder G, Fortin M-A, Ebacher A, Milosevic M. Radiosurgery scope of practice in Canada: A report of the Canadian Association of Radiation Oncology (CARO) Advisory Committee. Radiother Oncol 2010 April;95(1):122-128.
3. Olson R, Tyldesley S, Carolan H, Parkinson M, Chhanabhai T, McKenzie M. Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases. Support Care Cancer 2011;19(11):1849-1855.
4. Oliffe JL, Bottorff JL, McKenzie MR, Hislop TG, , Gerbrandt JS, Oglov V. Prostate cancer support groups, health literacy and consumerism: Are community-based volunteers re-defining men’s health promotion? Health (London). 2010 Dec 22. [Epub ahead of print].
5. Herbert C, Morris WJ, Hamm J, Lapointe V, McKenzie M, Pickles T, Spadinger I, Keyes M. The effect of loose vs. stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapy. Brachytherapy. 2011 Nov-Dec;10(6):442-4488.
6. Olson RA, Iverson GL, Carolan H, Parkinson M, Brooks BL, McKenzie M. Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life. J Neurooncol. 2011;105(2):337-344.
7. Herbert C, Moiseenko V, McKenzie M, Redekop G, Hsu F, Gete E, Gill, Lee R, Luchka K, Lee A, Haw C, Toyota B, Martin M. Factors predictive of obliteration after arteriovenous malformation radiosurgery. Can J Neurosciences 2011 Nov;38(11):845-850.
8. Herbert C, Moiseenko V, McKenzie M, Redekop G, Hsu F, Gete E, Gill B, Lee R, Luchka K, Haw C, Lee A, Toyota B, Martin M. Factors predictive of symptomatic radiation injury after linear accelerator-based stereotactic radiosurgery for intracerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys 2012; 83(3):872-877.
9. Keyes M, Spadinger I, Liu M, Pickles T, Pai H, Hayden A, Moravan V, Halperin R, McKenzie M, Kwan W, Agranovic A, Lapointe V, Morris WJ. Rectal toxicity and rectal dosimetry in low-dose-rate iodine-125 permanent prostate implants: A long-term study in 1006 patients. Brachytherapy. 2012 May-Jun;11(3):199-208.
10. Herbert C, Morris WJ, Keyes M, Hamm J, Lapointe V, McKenzie M, Pickles T, Spadinger I. Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: a population-based cohort study. Radiother Oncol 2012 May;103(2):228-32.
* The British Columbia Cancer Agency (BCCA)-Vancouver Centre (VC) is the largest academic cancer centre for the BCCA, located in downtown Vancouver and treating about one third of the radiation oncology cancer patients in the Province of BC. Over 4360 cancer patients are seen each year in the radiation oncology department. There are 20 Radiation Oncology (RO) physician faculty with full disease site specialization and clinical programs of excellence, 2 General Practice (Internist) Oncology Physicians, 3 Clinical Fellows and 10 RO residents. The BCCA-Vancouver Centre also has 17 physicists and a graduate training program in physics, 15 nurses, >60 radiation therapists clerks, secretaries and many others within radiation oncology. General capabilities include 9 Linacs (including Truebeam), 1 cobalt, VMAT (first developed in the BCCA-VC), IMRT, SBRT, IGRT, HDR and LDR brachytherapy suites, and Protons (at the TRIUMF centre). The Vancouver Centre radiation oncology department conducts all levels of research (basic, translational, clinical, population), and is the main educational institution in BC for the training of graduate (residents) and undergraduate (medical) students. The interdisciplinary Radiation Oncology team is part of the even larger multidisciplinary and provincial teams.